Sequoia Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.9M | Buy |
94,884
+4,420
| +5% | +$951K | 0.12% | 126 |
|
|
2026
Q1 | $19.7M | Sell |
90,464
-1,199
| -1% | -$266K | 0.11% | 128 |
|
|
2025
Q4 | $20.9M | Buy |
91,663
+7,169
| +8% | +$1.63M | 0.12% | 126 |
|
|
2025
Q3 | $19.6M | Buy |
84,494
+4,785
| +6% | +$974K | 0.12% | 121 |
|
|
2025
Q2 | $14.8M | Buy |
79,709
+3,136
| +4% | +$583K | 0.1% | 153 |
|
|
2025
Q1 | $16M | Buy |
76,573
+6,978
| +10% | +$1.36M | 0.12% | 144 |
|
|
2024
Q4 | $12.4M | Buy |
69,595
+1,146
| +2% | +$211K | 0.12% | 152 |
|
|
2024
Q3 | $13.5M | Buy |
68,449
+13,048
| +24% | +$2.44M | 0.15% | 130 |
|
|
2024
Q2 | $9.5M | Buy |
55,401
+1,189
| +2% | +$197K | 0.11% | 137 |
|
|
2024
Q1 | $9.87M | Sell |
54,212
-10,873
| -17% | -$1.87M | 0.12% | 140 |
|
|
2023
Q4 | $10.1M | Buy |
65,085
+25,923
| +66% | +$3.78M | 0.13% | 144 |
|
|
2023
Q3 | $5.84M | Buy |
39,162
+1,599
| +4% | +$235K | 0.1% | 140 |
|
|
2023
Q2 | $5.06M | Buy |
37,563
+137
| +0.4% | +$20.1K | 0.09% | 157 |
|
|
2023
Q1 | $5.96M | Buy |
37,426
+825
| +2% | +$126K | 0.13% | 134 |
|
|
2022
Q4 | $5.92M | Sell |
36,601
-7,172
| -16% | -$1.1M | 0.15% | 129 |
|
|
2022
Q3 | $5.88M | Sell |
43,773
-2,821
| -6% | -$405K | 0.19% | 100 |
|
|
2022
Q2 | $7.14M | Sell |
46,594
-8,362
| -15% | -$1.28M | 0.2% | 93 |
|
|
2022
Q1 | $8.91M | Sell |
54,956
-19,235
| -26% | -$2.79M | 0.22% | 92 |
|
|
2021
Q4 | $10M | Buy |
74,191
+59,716
| +413% | +$7.05M | 0.27% | 77 |
|
|
2021
Q3 | $1.56M | Sell |
14,475
-42,152
| -74% | -$4.82M | 0.16% | 84 |
|
|
2021
Q2 | $6.38M | Buy |
56,627
+10,848
| +24% | +$1.22M | 0.23% | 79 |
|
|
2021
Q1 | $4.95M | Buy |
45,779
+1,430
| +3% | +$153K | 0.21% | 76 |
|
|
2020
Q4 | $4.75M | Buy |
44,349
+3,917
| +10% | +$376K | 0.22% | 65 |
|
|
2020
Q3 | $3.54M | Buy |
40,432
+1,851
| +5% | +$174K | 0.19% | 72 |
|
|
2020
Q2 | $3.79M | Buy |
38,581
+3,894
| +11% | +$343K | 0.22% | 58 |
|
|
2020
Q1 | $2.64M | Buy |
34,687
+8,176
| +31% | +$696K | 0.2% | 65 |
|
|
2019
Q4 | $2.35M | Buy |
26,511
+14,169
| +115% | +$1.18M | 0.15% | 87 |
|
|
2019
Q3 | $935K | Buy |
12,342
+2,009
| +19% | +$138K | 0.07% | 134 |
|
|
2019
Q2 | $751K | Buy |
10,333
+918
| +10% | +$72.2K | 0.06% | 146 |
|
|
2019
Q1 | $759K | Buy |
9,415
+1,135
| +14% | +$92.9K | 0.06% | 143 |
|
|
2018
Q4 | $763K | Buy |
8,280
+1,102
| +15% | +$96.9K | 0.09% | 120 |
|
|
2018
Q3 | $679K | Sell |
7,178
-307
| -4% | -$29.1K | 0.07% | 136 |
|
|
2018
Q2 | $694K | Buy |
7,485
+250
| +3% | +$24.4K | 0.07% | 130 |
|
|
2018
Q1 | $685K | Buy |
7,235
+2,252
| +45% | +$247K | 0.07% | 129 |
|
|
2017
Q4 | $482K | Buy |
4,983
+61
| +1% | +$5.75K | 0.05% | 171 |
|
|
2017
Q3 | $437K | Buy |
4,922
+33
| +0.7% | +$2.51K | 0.05% | 168 |
|
|
2017
Q2 | $355K | Buy |
4,889
+512
| +12% | +$34.4K | 0.04% | 185 |
|
|
2017
Q1 | $285K | Buy |
4,377
+759
| +21% | +$47.7K | 0.04% | 204 |
|
|
2016
Q4 | $227K | Buy |
3,618
+224
| +7% | +$13.7K | 0.03% | 240 |
|
|
2016
Q3 | $214K | Buy |
3,394
+127
| +4% | +$8.22K | 0.04% | 219 |
|
|
2016
Q2 | $202K | Sell |
3,267
-273
| -8% | -$16.6K | 0.06% | 226 |
|
|
2016
Q1 | $202K | Buy |
+3,540
| New | +$197K | 0.07% | 181 |
|
|
2015
Q3 | – | Sell |
-3,318
| Closed | -$223K | – | 173 |
|
|
2015
Q2 | $223K | Buy |
+3,318
| New | +$217K | 0.09% | 169 |
|
Other funds holding ABBV
Sequoia Financial Advisors's ABBV Position: Q2 2026 in Review
Sequoia Financial Advisors increased its AbbVie (ABBV) stake by 4.9% in Q2 2026, buying an estimated $951K and bringing the position to 94,884 shares worth $23.9M. The position accounts for 0.12% of the portfolio, ranked #126.
Sequoia Financial Advisors first reported a position in ABBV in Q2 2015 and has held it in 43 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sequoia Financial Advisors held 94,884 shares of AbbVie worth $23.9M as of Q2 2026.
- Sequoia Financial Advisors bought 4,420 AbbVie shares in Q2 2026, an estimated $951K.
- AbbVie made up 0.12% of Sequoia Financial Advisors's portfolio in Q2 2026, its #126 holding.
- Sequoia Financial Advisors first reported a position in AbbVie in Q2 2015 and has held it in 43 quarters since.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.